Literature DB >> 16368887

Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.

Claudio Talora1, Samantha Cialfi, Christian Oliviero, Rocco Palermo, Monica Pascucci, Luigi Frati, Alessandra Vacca, Alberto Gulino, Isabella Screpanti.   

Abstract

Integrated pathways are believed to determine hematopoietic cell fate and/or neoplastic transformation. Notch signaling has been shown to regulate T-cell differentiation and leukemogenesis. However, specific target genes and molecular partners are not fully elucidated. We show that Notch3 activation sustains aberrant SCL/Tal1 overexpression and phosphorylation in mature thymocytes. Furthermore, we define the role of SCL/Tal1 as a component of an activator complex, including phosphorylated Tal1 and Sp1, that specifically enhances cyclin D1 expression and demonstrate that Tal1/Sp1 specifically co-occupy the D1 promoter in vivo, only in the presence of pre-T-cell receptor (TCR). We therefore conclude not only that cyclin D1 is a target of the Tal1/Sp1 complex, but also that Notch3-dependent activation of pre-TCR/ERK signaling regulates SCL/Tal1 function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368887     DOI: 10.1182/blood-2005-07-2823

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

Authors:  Shiori Saito; Jiro Kikuchi; Daisuke Koyama; Shin Sato; Hiroo Koyama; Naoki Osada; Yoshiaki Kuroda; Koshi Akahane; Takeshi Inukai; Takashi Umehara; Yusuke Furukawa
Journal:  Clin Cancer Res       Date:  2018-12-05       Impact factor: 12.531

2.  Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation.

Authors:  Kyung-Ah Kim; Jung-Hyun Kim; Yuhui Wang; Hei Sook Sul
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

Review 3.  Novel insights into the development of T-cell acute lymphoblastic leukemia.

Authors:  Frank J T Staal; Jacques J M van Dongen; Anton W Langerak
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

4.  Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.

Authors:  Mai Xu; Qing Yu; Ramesh Subrahmanyam; Michael J Difilippantonio; Thomas Ried; Jyoti Misra Sen
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

5.  Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

Authors:  V Kumar; R Palermo; C Talora; A F Campese; S Checquolo; D Bellavia; L Tottone; G Testa; E Miele; S Indraccolo; A Amadori; E Ferretti; A Gulino; A Vacca; I Screpanti
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 11.528

6.  Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.

Authors:  Joon T Park; Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

Review 7.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

8.  Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response.

Authors:  David E Phelan; Masahiko Shigemura; Sarah Aldhafiri; Catarina Mota; Thomas J Hall; Jacob I Sznajder; Evelyn P Murphy; Daniel Crean; Eoin P Cummins
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  Protein kinase C signaling and cell cycle regulation.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Front Immunol       Date:  2013-01-17       Impact factor: 7.561

10.  Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.

Authors:  Shao-Qing Kuang; Zhihong Fang; Patrick A Zweidler-McKay; Hui Yang; Yue Wei; Emilio A Gonzalez-Cervantes; Yanis Boumber; Guillermo Garcia-Manero
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.